Amaero Inc., a U.S.-based producer of titanium alloy powders and advanced manufacturing components, priced its initial public offering at $4.25 per share for 4.7 million shares. The shares are set to begin trading on the Nasdaq Capital Market on October 15, 2026, under the ticker AMRO. Amaero plans to use about $10 million from the proceeds to buy capital equipment and the rest for general corporate purposes including R&D and operating expenses. The offering is expected to close on October 16, 2026, pending customary closing conditions.
Amaero Inc. pricing of its U.S. IPO offers context for market watchers. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 15, 2026 03:23 WIB: Out of 83 priced US Basic Materials stocks, 16 rose and 67 fell today. Notable movers include IAUX at USD 1.45, down 6.17%, SVM at USD 9.42, down 6.08%, and NG at USD 6.24, down 5.88%.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
